-Responsible for research on, and the forecasting of, Biotech and Medtech equity markets as well as setting the subsectors asset allocation.-Writing thematic research articles.-Provide forecasts for, and research and commentary on, key healthcare data and financial market variables.

- Fundamental analysis of companies in both our healthcare portfolios: Biotech & Bionics.- Assist PM for portfolio construction.

- Performing fundamental analysis of companies in the biotech portfolio.- Scouting new technologies and trends in the healthcare sector.- Generation of research documents.

- Research in the regulation of intracellular killing of ingested bacteria by phagocytic cells.- 4 peer-reviewed papers: Links below.- Won UNIGE "ma thèse en 180 secondes" science populrization contest.

Master 2 - System & Synthetic Biology internship.- Was part of the MEGA team with the aim to prove with a synthetic genetic construct that co-regulated genes in E.coli are not randomly spaced which would enable us to optimize heterologous expression of genes in E.coli to boost productivity and yield for high value compounds.- Was in charge of the implementation of a new cloning technique in the laboratory.

Top50 Pharma, Belgium, XEVMPD Coordinator (start/end: April/september 2012)− Collecting, storing, managing pharmacovigilance data from GRA and Affiliates in the EU.− Design routine processes for XEVMPD future maintenance.− Member of the regulatory tracking team to ensure alignment and compliance of the Registration and Tracking system with the Eudravigilance database.ProductLife AG, Nyon, Quality manager (start/end: January 2012/August 2013)− ISO 9001:2008 Certification from scratch obtained January 2013.− ISO 9001:2008 Certification involvement in the Group certification..ProductLife AG, Nyon, Business Development manager (start/end: January/-)− Prospection & Account management: Biotech/ MedTech / Pharma, regarding PV, QA ,RA.− Active participation in the 30% growth of PL AG.

- Worked as Project leader for Viral Risk Assessment and member of the stirring corporate committee for large scale contamination prevention & decontamination.- Was in charge of assessing the viral safety of drug-related processes on the main Suite.- Was able to successfully implement Viral Risk Assessment on site, this initiative has been spread to 4 Biotech-sites.

- Worked as the Laboratory Student Team manager and Laboratory worker, in order to design and engineer a robust inter-cellular communication system based on outer membrane vesicles.- Was in charge of designing the experiments, synchronizing the teamwork.- Build with the team a wiki: http://2009.igem.org/Team:Paris- Awarded, along with all the team, a Gold medal and the Human Practice Advance Award.